SCHEMBL27017931

SCHEMBL27017931

c1ccc(-c2ccc(-c3c(-c4ccc5c(c4)oc4ccccc45)cccc3N(c3cccc(-c4ccccc4)c3)c3ccc4c5ccccc5c5ccccc5c4c3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ PRKDC P78527 1/20 0.33
▸ PLA2G2A P14555 3/20 0.33
▸ PLA2G4A P47712 3/20 0.33
▸ AHR P35869 2/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27017770 0.96 MMP12 (0.36) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27018261 0.94 ALOX5 (0.34) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27017951 0.92 PLA2G2A (0.38) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27017944 0.92 MMP12 (0.36) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27018032 0.91 PLA2G2A (0.38) MMP12MMP13ALOX5PRKDCPLA2G2A
SCHEMBL27017857 0.91 MMP12 (0.36) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27017862 0.91 MMP12 (0.36) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27017718 0.91 ALOX5 (0.39) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27017760 0.90 ALOX5 (0.35) MMP12MMP13ALOX5HCRTR1PRKDC
SCHEMBL27018870 0.90 MMP12 (0.36) MMP12MMP13ALOX5HCRTR1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023428-A1 ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-18 — — US disclosed
US-20240023428-A1 ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023428-A1 ORGANIC ELECTROLUMINESCENT MATERIAL, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE L1CAM, EPCAM, SELE MMP12 1924/4885MMP13 4137/4885ALOX5 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback